BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Chen QY, Mo H, Zhang YL, Huang ZF, Zeng YX. Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy. Int J Biol Sci 2011;7:607-17. [PMID: 21614153 DOI: 10.7150/ijbs.7.607] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS, Zhang XS, Cui J, Zeng YX, Li J. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-5452. [PMID: 24978137 DOI: 10.18632/oncotarget.2118] [Cited by in Crossref: 191] [Cited by in F6Publishing: 186] [Article Influence: 27.3] [Reference Citation Analysis]
2 Lin M, Yuan Y, Xu J, Cai X, Liu S, Niu L, Chen J, Li Q, Xu K. Safety and efficacy study of nasopharyngeal cancer stem cell vaccine. Immunol Lett 2015;165:26-31. [PMID: 25796196 DOI: 10.1016/j.imlet.2015.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 He J, Tang XF, Chen QY, Mai HQ, Huang ZF, Li J, Zeng YX. Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy. Chin J Cancer 2012;31:287-94. [PMID: 22257383 DOI: 10.5732/cjc.011.10376] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
4 Chen CY, Lin YS, Chen CL, Chao PZ, Chiou JF, Kuo CC, Lee FP, Lin YF, Sung YH, Lin YT, Li CF, Chen YJ, Chen CH. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma. Oncotarget 2015;6:26946-59. [PMID: 26196246 DOI: 10.18632/oncotarget.4521] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
5 Gourzones C, Barjon C, Busson P. Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol. 2012;22:127-136. [PMID: 22249142 DOI: 10.1016/j.semcancer.2012.01.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
6 Chen CY, Lin YS, Chen CH, Chen YJ. Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma. J Biomed Sci. 2018;25:30. [PMID: 29598816 DOI: 10.1186/s12929-018-0430-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
7 Perri F, Della Vittoria Scarpati G, Giuliano M, D'Aniello C, Gnoni A, Cavaliere C, Licchetta A, Pisconti S. Epstein-Barr virus infection and nasopharyngeal carcinoma: the other side of the coin. Anticancer Drugs 2015;26:1017-25. [PMID: 26241803 DOI: 10.1097/CAD.0000000000000276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
8 Martorelli D, Muraro E, Merlo A, Turrini R, Faè DA, Rosato A, Dolcetti R. Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders. Clin Dev Immunol 2012;2012:931952. [PMID: 22319542 DOI: 10.1155/2012/931952] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
9 Shen Y, Zhang S, Sun R, Wu T, Qian J. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients. Emerg Microbes Infect 2015;4:e20. [PMID: 26038769 DOI: 10.1038/emi.2015.20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
10 Fogg M, Murphy JR, Lorch J, Posner M, Wang F. Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma. Virology 2013;441:107-13. [PMID: 23601786 DOI: 10.1016/j.virol.2013.03.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]